Back to search results

Audio Recording in Outpatient Supportive Cancer Care

This study looks at how helpful audio recordings are for patients with advanced cancer during their supportive care visits. You would use a recording device, like your phone, to record parts of your clinic visit. Researchers want to know if these recordings help you remember information and share it with family or caregivers who weren't there. The main goal is to see if you find the recordings useful after your visit and if they help you talk about your medical condition with others. This study is for adults aged 18 and older who have locally advanced, recurrent, or metastatic solid or liquid tumors and are seen at M.D. Anderson Cancer Center's supportive care center. The study aims to enroll 200 participants and is currently ongoing.

Study design
This is an observational study involving 200 participants. It is not randomized or blinded.
What's involved
You would audio record parts of your clinic visit and complete questionnaires. The study will track your perceptions for about one year.
Compensation
Not stated in the trial record.
Follow-up
Your perceptions will be measured through study completion, which is an average of one year.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT04871477

Adoption of Audio Recording in the Outpatient Supportive Care Center

Not Yet Recruiting
Not specifiedAges 18+Observational
M.D. Anderson Cancer Center
~200 participants
Updated 2026-07-16 on ClinicalTrials.gov
What's tested:Communication InterventionQuestionnaire Administration

At a glance

Recruiting sites
0 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Proportion of patients who will select "Complete Agree/Partially Agree" in Question 1 "I found the audio recording useful after the visit"
Measured over through study completion, an average of 1 year
+1 more outcome measured

Conditions

Advanced Malignant Solid Neoplasm
Hematopoietic and Lymphoid Cell Neoplasm
Locally Advanced Malignant Solid Neoplasm
Metastatic Malignant Solid Neoplasm
Recurrent Malignant Solid Neoplasm

Explore related trials

Hematologic NeoplasmSolid Neoplasm

NCT04871477

Where you'd take part

This study runs at 1 site. They're the same protocol — you choose where, and that choice sets who your contact draft is addressed to.

  • M D Anderson Cancer Center

    Houston, Texasstudy coordinator listed

Sites open and close at different times, so the status above is per site — it can differ from the study's overall status.

Study leadership

  • Michael J Tang · PRINCIPAL_INVESTIGATOR · M.D. Anderson Cancer Center

Who to contact

Michael Tang, MD
[email protected]
832-468-8895
Email the study team

Opens a ready-to-send draft in your own email app — review before sending.

Want this trial checked against your situation?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

Patients with the diagnosis of advanced cancer as defined as locally advanced, recurrent or metastatic cancer. Both solid and liquid tumors are eligible for the study
Patients who are seen in the outpatient supportive care center at M.D. Anderson Cancer Center
Patients who have access to a recording device or cellphone with recording technology
Patients who can be contacted 7 to 11 days from the clinic visit that the recording took place
Patients who can sign informed consent
Patients who are able to read and write in English
Patients 18 years or older

Exclusion

Patients who have been diagnosed with delirium or cognitive impairment. This will be defined by chart review along with review of the MD Anderson Symptom Inventory (MDAS) the day of clinic visit. An MDAS of 7 or greater will be considered to define delirium in this study
Patients who are unwilling to sign informed consent
Patients who have used audio recordings before in clinic visits
Patients who have severe hearing impairments without access to assisted devices or programs to aid in listening to the recorded material

What this trial measures

  • Proportion of patients who will select "Complete Agree/Partially Agree" in Question 1 "I found the audio recording useful after the visit"through study completion, an average of 1 year

    Will be summarized using proportion along with a 95% confidence interval.

  • Proportion of patients who will select "Complete Agree/Partially Agree" in Question 2 "I was able to effectively discuss my medical condition with my family member(s) and/or caregiver(s) who were not present at the clinical visitthrough study completion, an average of 1 year

    Will be summarized using proportion along with a 95% confidence interval.